Telecare Effective in Improving Pain Management
the Neurology Advisor take:
Telecare collaborative management can help primary-care patients better manage their chronic musculoskeletal pain, according to a study published in JAMA.Optimizing nonopioid analgesic medications using a stepped care algorithm and monitoring increased the proportion of patients with improved chronic musculoskeletal pain, Kurt Kroenke, MD, of the Indiana University School of Medicine in Indianapolis, and colleagues found.
The study included 250 patients with chronic musculoskeletal pain of at least moderate intensity (≥3 months, Brief Pain Inventory [BPI] score ≥5). The patients were enrolled from five primary care clinics in one Veterans Affairs medical center from June 2010 through May 2012. A 12-month follow-up was completed by June 2013.
Patients were randomly assigned to telephone-delivered collaborative care management intervention (n=124) or to usual care, where they received all pain care as usual from their primary care physicians (n=126). The intervention group received 12 months of telecare management that combined automated symptom monitoring with an algorithm-guided stepped-care approach to optimizing analgesics.
Mean baseline BPI scores in the intervention and control groups were 5.31 and 5.12, respectively. After 12 months, the intervention group had a 1.02-point lower BPI score compared with the usual care group. In the intervention group, 51.7% reported at least a 30% improvement in their pain score, compared with just 27.1% of the usual care group.
Telecare Effectively Improves Pain Management
The purpose of this study was to determine the effectiveness of a telecare intervention for chronic pain.
Kurt Kroenke, MD, of the Indiana University School of Medicine in Indianapolis, and colleagues found that telecare collaborative management increased the proportion of primary care patients with improved chronic musculoskeletal pain. This was accomplished by optimizing nonopioid analgesic medications using a stepped care algorithm and monitoring.
After 12 months, the intervention group had a 1.02-point lower BPI score compared with the usual care group. In the intervention group, 51.7% reported at least a 30% improvement in their pain score, compared with just 27.1% of the usual care group.
Next Article in Pain
Neurology Advisor Articles
- Clarifying Cardiovascular Risk in Migraine
- Parkinson Disease Symptom Fluctuations Well-Managed With Adaptive Deep Brain Stimulation
- More Evidence Supports Benefits of Cannabidiol for Treatment-Resistant Epilepsy
- Monthly Erenumab Reduces Frequency of Episodic Migraine
- Reduced Risk for Multiple Sclerosis Linked to Greater Sun Exposure
- Tamsulosin Associated With Dementia Risk in Older Patients With BPH
- FDA Approves Blood Test to Assess Concussion
- Gait Difficulty in Parkinson Disease May Be Associated With More Progressive Disease Course
- Tau PET a Useful Biomarker for Alzheimer Disease Risk and Progression
- Multiple Sclerosis Drug Zinbryta Withdrawn From the Market
- Incidence of Delayed Traumatic Intracranial Hemorrhage Low in Older Adults With Blunt Head Trauma
- Older Epilepsy Patients More Likely to Experience AED, Non-AED Drug Interaction
- Female Gender, Natalizumab Exposure Associated With Increased Lymphopenia Risk in FNG-Treated MS
- Accelerated Cognitive Decline Associated With Retinopathy
- Treatment Effects Often Exaggerated in Early Clinical Studies